Back to Results
First PageMeta Content
Biopharmaceuticals / Debiopharm / Pharmaceutical industry


PRESS RELEASE Debiopharm Group™ and TCG Lifesciences Ltd. announce successful completion of first phase of research collaboration on discovery of novel antibiotics Lausanne, Switzerland and Kolkata, India – June 24 2
Add to Reading List

Document Date: 2014-06-25 05:09:33


Open Document

File Size: 167,23 KB

Share Result on Facebook

City

Kolkata / Lausanne / /

Company

PRESS RELEASE Debiopharm Group / Debiopharm International SA / TCG Lifesciences Ltd. / New York Russo Partners LLC / Debiopharm Group / /

Continent

Europe / /

Country

Switzerland / Japan / United States / Australia / India / /

/

Event

Business Partnership / /

IndustryTerm

biopharmaceutical / pharmaceutical partners / manufacturing / /

MedicalCondition

skin-structure infections / hospital-acquired infections / skin infections / Infectious Diseases / Metabolic Disorders / Inflammation / /

MedicalTreatment

antibiotics / /

Person

Saumitra Sengupta / Andrés McAllister / Martina Schwarzkopf / Christelle Tur / /

/

Position

Chief Scientific Officer / Executive / Communication Coordinator / Contact Rakesh C. Pandya Head / Distinguished Scientist / /

Product

FabI / /

Technology

drug discovery / drug development / /

URL

www.tcgls.com / www.debiopharm.com / /

SocialTag